Dr. Agarwal's Eye [DRAGARWQ] vs Shalby [SHALBY] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Dr. Agarwal's Eye Hospital Ltd. wins in 14 metrics, Shalby Ltd. wins in 6 metrics, with 0 ties. Dr. Agarwal's Eye Hospital Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dr. Agarwal's Eye Hospital Ltd. | Shalby Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.01 | 207.28 | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Book Ratio | 7.52 | 1.75 | Shalby Ltd. |
| Debt-to-Equity Ratio | 106.45 | 53.32 | Shalby Ltd. |
| PEG Ratio | 1.81 | -1.45 | Dr. Agarwal's Eye Hospital Ltd. |
| EV/EBITDA | 20.64 | 16.45 | Shalby Ltd. |
| Profit Margin (TTM) | 15.50% | 0.72% | Dr. Agarwal's Eye Hospital Ltd. |
| Operating Margin (TTM) | 19.54% | 4.65% | Dr. Agarwal's Eye Hospital Ltd. |
| EBITDA Margin (TTM) | 19.54% | 4.65% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Equity | 26.07% | 0.63% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Assets (TTM) | 8.91% | 0.37% | Dr. Agarwal's Eye Hospital Ltd. |
| Free Cash Flow (TTM) | $-83.80M | $-757.89M | Dr. Agarwal's Eye Hospital Ltd. |
| Dividend Yield | 0.11% | 0.65% | Shalby Ltd. |
| 1-Year Return | 12.35% | -6.18% | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Sales Ratio (TTM) | 5.39 | 1.55 | Shalby Ltd. |
| Enterprise Value | $26.69B | $22.59B | Dr. Agarwal's Eye Hospital Ltd. |
| EV/Revenue Ratio | 5.92 | 2.02 | Shalby Ltd. |
| Gross Profit Margin (TTM) | 78.09% | 41.11% | Dr. Agarwal's Eye Hospital Ltd. |
| Revenue per Share (TTM) | $952 | $101 | Dr. Agarwal's Eye Hospital Ltd. |
| Earnings per Share (Diluted) | $147.68 | $0.78 | Dr. Agarwal's Eye Hospital Ltd. |
| Beta (Stock Volatility) | -0.57 | 0.47 | Dr. Agarwal's Eye Hospital Ltd. |
Dr. Agarwal's Eye Hospital Ltd. vs Shalby Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye Hospital Ltd. | 0.58% | 0.12% | -1.62% | 6.94% | -8.52% | -6.31% |
| Shalby Ltd. | 1.00% | -0.43% | 7.91% | 21.73% | -12.46% | -15.93% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye Hospital Ltd. | 12.35% | 240.02% | 1,131.89% | 2,480.68% | 5,282.48% | 17,498.05% |
| Shalby Ltd. | -6.18% | 10.56% | 5.52% | -29.49% | -29.49% | -29.49% |
Performance & Financial Health Analysis: Dr. Agarwal's Eye Hospital Ltd. vs Shalby Ltd.
| Metric | DRAGARWQ | SHALBY |
|---|---|---|
| Market Information | ||
| Market Cap | ₹24.28B | ₹16.70B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,256 | 80,346 |
| 90 Day Avg. Volume | 1,378 | 143,083 |
| Last Close | ₹4,991.20 | ₹170.62 |
| 52 Week Range | ₹4,142.00 - ₹6,392.00 | ₹125.82 - ₹274.70 |
| % from 52W High | -21.91% | -37.89% |
| All-Time High | ₹7,300.00 (Dec 30, 2024) | ₹339.50 (Jan 22, 2024) |
| % from All-Time High | -31.63% | -49.74% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.22% | -0.01% |
| Quarterly Earnings Growth | 0.66% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | 0.01% |
| Operating Margin (TTM) | 0.20% | 0.05% |
| Return on Equity (TTM) | 0.26% | 0.01% |
| Debt to Equity (MRQ) | 106.45 | 53.32 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹668.22 | ₹92.31 |
| Cash per Share (MRQ) | ₹191.98 | ₹1.77 |
| Operating Cash Flow (TTM) | ₹738.70M | ₹-417,020,000 |
| Levered Free Cash Flow (TTM) | ₹546.50M | ₹62.22M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.11% | 0.65% |
| Last 12-Month Dividend | ₹5.00 | ₹1.20 |
Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye Hospital Ltd. vs Shalby Ltd.
| Metric | DRAGARWQ (Apr 26, 2026) | SHALBY (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.01 | 207.28 |
| Forward P/E | 516.77 | 17.20 |
| PEG Ratio | 1.81 | -1.45 |
| Price to Sales (TTM) | 5.39 | 1.55 |
| Price to Book (MRQ) | 7.52 | 1.75 |
| Market Capitalization | ||
| Market Capitalization | ₹24.28B | ₹16.70B |
| Enterprise Value | ₹26.69B | ₹22.59B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.92 | 2.02 |
| Enterprise to EBITDA | 20.64 | 16.45 |
| Risk & Other Metrics | ||
| Beta | -0.57 | 0.47 |
| Book Value per Share (MRQ) | ₹668.22 | ₹92.31 |
Financial Statements Comparison: Dr. Agarwal's Eye Hospital Ltd. vs Shalby Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DRAGARWQ (2025) | SHALBY (2025) |
|---|---|---|
| Revenue/Sales | 3.94B | 10.81B |
| Cost of Goods Sold | 896.20M | 6.35B |
| COGS % of Revenue | 22.8% | 58.8% |
| Gross Profit | 3.04B | 4.46B |
| Gross Margin | 77.2% | 41.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 813.30M | 779.43M |
| Operating Margin | 20.6% | 7.2% |
| EBITDA | 1.22B | 1.51B |
| EBITDA Margin | 31.1% | 14.0% |
| Pre-Tax Income | 707.00M | 557.29M |
| Pre-Tax Income % of Revenue | 17.9% | 5.2% |
| Income Tax | 160.50M | 538.09M |
| Income Tax % of Revenue | 4.1% | 5.0% |
| Net Income (Profit) | 546.50M | 19.20M |
| Profit Margin | 13.9% | 0.2% |
Balance Sheet & Liquidity Metrics
| Metric | DRAGARWQ (2025) | SHALBY (2025) |
|---|---|---|
| Cash & Equivalents | 111.60M | 347.85M |
| Total Current Assets | 559.40M | 6.58B |
| Total Current Assets % of Revenue | 14.2% | 60.9% |
| Total Current Liabilities | 869.80M | 4.55B |
| Total Current Liabilities % of Revenue | 22.1% | 42.1% |
| Long-Term Debt | 3.06B | 1.75B |
| Long-Term Debt % of Revenue | 77.6% | 16.2% |
| Total Shareholders Equity | 2.10B | 9.95B |
| Retained Earnings | 1.99B | 4.44B |
| Retained Earnings % of Revenue | 50.4% | 41.1% |
| Property, Plant & Equipment | 1.37B | 4.36B |
Cash Flow Statement Comparison
| Metric | DRAGARWQ (2025) | SHALBY (2025) |
|---|---|---|
| Operating Cash Flow | 738.70M | -417.02M |
| Operating Cash Flow % of Revenue | 18.8% | -3.9% |
| Capital Expenditures | 4.10M | -700.85M |
| Free Cash Flow | -83.80M | -757.89M |
| FCF Margin | -2.1% | -7.0% |
| Debt Repayment | -111.30M | -393.05M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DRAGARWQ | SHALBY |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 4.83M | 107.30M |
| Float Shares | 1.08M | 26.51M |
| % Held by Insiders | 77.59% | 76.11% |
| % Held by Institutions | 3.57% | 0.07% |
| % Held by Public | 18.84% | 23.82% |
Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye Hospital Ltd. vs Shalby Ltd.
| Metric | DRAGARWQ | SHALBY |
|---|---|---|
| Last 12-Month Dividend | ₹5.00 | ₹1.20 |
| Last 12-Month Dividend Yield | 0.11% | 0.65% |
| 3-Year Avg Annual Dividend | ₹4.50 | ₹1.08 |
| 3-Year Avg Dividend Yield | 0.12% | 0.55% |
| 3-Year Total Dividends | ₹13.50 | ₹3.23 |
| Ex-Dividend Date | Nov 08, 2024 | Sep 19, 2024 |